|Bid||18.32 x 800|
|Ask||18.44 x 900|
|Day's Range||18.25 - 18.49|
|52 Week Range||11.48 - 19.50|
|Beta (5Y Monthly)||1.67|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 06, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||19.00|
NEW YORK, NY / ACCESSWIRE / September 26, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating:Cellular Biomedicine Group, Inc.
NEW YORK, NY / ACCESSWIRE / September 25, 2020 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating: * Pfenex Inc.
Akcea Therapeutics, Inc. (NASDAQ: AKCA)